684 related articles for article (PubMed ID: 11691969)
21. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
22. Smallpox and bioterrorism.
Drazen JM
N Engl J Med; 2002 Apr; 346(17):1262-3. PubMed ID: 11923485
[No Abstract] [Full Text] [Related]
23. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometry and T-cell response monitoring after smallpox vaccination.
Poccia F; Gioia C; Montesano C; Martini F; Horejsh D; Castilletti C; Pucillo Lp; Capobianchi MR; Ippolito G
Emerg Infect Dis; 2003 Nov; 9(11):1468-70. PubMed ID: 14718095
[TBL] [Abstract][Full Text] [Related]
25. [A study of children repeatedly negative after smallpox vaccination].
Bergmannová V; Stehlíková J; Smetana K
Cesk Pediatr; 1981 May; 36(5):267-70. PubMed ID: 6266678
[No Abstract] [Full Text] [Related]
26. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
Hughes CM; Newman FK; Davidson WB; Olson VA; Smith SK; Holman RC; Yan L; Frey SE; Belshe RB; Karem KL; Damon IK
Clin Vaccine Immunol; 2012 Jul; 19(7):1116-8. PubMed ID: 22593237
[TBL] [Abstract][Full Text] [Related]
27. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA
J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340
[TBL] [Abstract][Full Text] [Related]
28. Smallpox vaccines: targets of protective immunity.
Moss B
Immunol Rev; 2011 Jan; 239(1):8-26. PubMed ID: 21198662
[TBL] [Abstract][Full Text] [Related]
29. The immunology of smallpox vaccines.
Kennedy RB; Ovsyannikova IG; Jacobson RM; Poland GA
Curr Opin Immunol; 2009 Jun; 21(3):314-20. PubMed ID: 19524427
[TBL] [Abstract][Full Text] [Related]
30. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
31. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the duration of vaccine-induced residual protection against severe and fatal smallpox based on secondary vaccination failure.
Nishiura H; Eichner M
Infection; 2006 Oct; 34(5):241-6. PubMed ID: 17033746
[TBL] [Abstract][Full Text] [Related]
33. Looking back at smallpox.
Bray M; Buller M
Clin Infect Dis; 2004 Mar; 38(6):882-9. PubMed ID: 14999635
[TBL] [Abstract][Full Text] [Related]
34. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
Bartlett JG
Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
[TBL] [Abstract][Full Text] [Related]
36. Smallpox, bioterrorism, and the neurologist.
Cleri DJ; Villota FJ; Porwancher RB
Arch Neurol; 2003 Apr; 60(4):489-94. PubMed ID: 12707060
[No Abstract] [Full Text] [Related]
37. Bioterrorism. How devastating would a smallpox attack really be?
Enserink M
Science; 2002 May; 296(5573):1592-5. PubMed ID: 12040157
[No Abstract] [Full Text] [Related]
38. Smallpox bioterror response.
Kaplan EH; Wein LM
Science; 2003 Jun; 300(5625):1503-4; author reply 1503-4. PubMed ID: 12791963
[No Abstract] [Full Text] [Related]
39. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
